- Home
- IGC vs INHD Comparison
IGC vs INHD Comparison
Compare IGC & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- INHD
- Stock Information
- Founded
- IGC 2005
- INHD 2019
- Country
- IGC United States
- INHD United States
- Employees
- IGC N/A
- INHD N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- INHD
- Sector
- IGC Health Care
- INHD
- Exchange
- IGC Nasdaq
- INHD Nasdaq
- Market Cap
- IGC 20.2M
- INHD 19.8M
- IPO Year
- IGC N/A
- INHD 2023
- Fundamental
- Price
- IGC $0.31
- INHD $1.40
- Analyst Decision
- IGC Strong Buy
- INHD
- Analyst Count
- IGC 2
- INHD 0
- Target Price
- IGC $3.88
- INHD N/A
- AVG Volume (30 Days)
- IGC 246.3K
- INHD 335.5K
- Earning Date
- IGC 06-27-2025
- INHD 08-11-2025
- Dividend Yield
- IGC N/A
- INHD N/A
- EPS Growth
- IGC N/A
- INHD N/A
- EPS
- IGC N/A
- INHD N/A
- Revenue
- IGC $1,271,000.00
- INHD $1,559,595.00
- Revenue This Year
- IGC $15.26
- INHD N/A
- Revenue Next Year
- IGC $3.41
- INHD N/A
- P/E Ratio
- IGC N/A
- INHD N/A
- Revenue Growth
- IGC N/A
- INHD 287.83
- 52 Week Low
- IGC $0.25
- INHD $1.11
- 52 Week High
- IGC $0.50
- INHD $19.78
- Technical
- Relative Strength Index (RSI)
- IGC 52.79
- INHD 39.00
- Support Level
- IGC $0.30
- INHD $1.34
- Resistance Level
- IGC $0.32
- INHD $1.48
- Average True Range (ATR)
- IGC 0.01
- INHD 0.15
- MACD
- IGC 0.00
- INHD 0.15
- Stochastic Oscillator
- IGC 33.33
- INHD 49.06
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.